Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $776.2M
Liabilities Breakdown FY2025
Total Liabilities: $68.8M
Asset Breakdown
Total Assets: $776.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $714.0M | 92.0% |
| Accounts Receivable | $2.1M | 0.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $844.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $59.3M | 7.6% |
Liabilities Breakdown
Total Liabilities: $68.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $17.7M | 25.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $51.1M | 74.3% |